1. Reid MJ, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, et al. Building a tuberculosis-free world: the Lancet Commission on tuberculosis. Lancet 2019;393:1331-84.
2. Uplekar M. Public-private mix for tuberculosis care and prevention. What progress? What prospects? Int J Tuberc Lung Dis 2016;20:1424-9.
3. Uplekar M. Involving private health care providers in delivery of TB care: global strategy. Tuberculosis (Edinb) 2003;83:156-64.
5. Park JS. Increasing the treatment success rate of tuberculosis in a private hospital through Public-Private Mix (PPM) project. Tuberc Respir Dis 2011;70:143-9.
6. Hong YP, Kim SJ, Lee EG, Lew WJ, Bai JY. Treatment of bacillary pulmonary tuberculosis at the chest clinics in the private sector in Korea, 1993. Int J Tuberc Lung Dis 1999;3:695-702.
7. Kim HJ, Bai GH, Kang MK, Kim SJ, Lee JK, Cho SI, et al. A public-private collaboration model for treatment intervention to improve outcomes in patients with tuberculosis in the private sector. Tuberc Respir Dis 2009;66:349-57.
9. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis in Korea. Cheongju: Korea Centers for Disease Control and Prevention; 2018.
10. Korea Centers for Disease Control and Prevention. Tuberculosis surveillance newsletter [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2020 [cited 2020 Mar 28]. Available from:
http://tbzero.cdc.go.kr.
11. Uplekar M, Lönnroth K; Stop TB Partnership; World Health Organization. Engaging all health care providers in TB control:guidance on implementing public-private mix approaches. Geneva: World Health Organization; 2006.
13. World Heatlh Organization. Definitions and reporting framework for tuberculosis: 2013 revision. 2013. Geneva: World Heatlh Organization; 2013.
14. Joint Committee for the Revision of Korean Guidelines for Tuberculosis; Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 3rd ed. Cheongju: Korea Centers for Disease Control and Prevention; 2017.
16. The Global Fund to Fight AIDS; Tuberculosis and Malaria. Monitoring and evaluation toolkit. 4th ed. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2011.
19. McCarthy KD, Metchock B, Kanphukiew A, Monkongdee P, Sinthuwattanawibool C, Tasaneeyapan T, et al. Monitoring the performance of mycobacteriology laboratories: a proposal for standardized indicators. Int J Tuberc Lung Dis 2008;12:1015-20.
20. Min J, Shin YM, Lee WJ, Truong TT, Kang ES, An JY, et al. Clinical features of octogenarian patients with tuberculosis at a tertiary hospital in South Korea. J Int Med Res 2019;47:271-80.
21. Kim H, Mok JH, Kang B, Lee T, Lee HK, Jang HJ, et al. Trend of multidrug and fluoroquinolone resistance in
Mycobacterium tuberculosis isolates from 2010 to 2014 in Korea: a multicenter study. Korean J Intern Med 2019;34:344-52.
22. Kwak N, Kim HR, Yoo CG, Kim YW, Han SK, Yim JJ. Multidrug-resistant tuberculosis over 20 years at a referral hospital in South Korea: trends and outcomes. Int J Tuberc Lung Dis 2019;23:174-80.
24. Min J, Kim JS. Diagnosis and treatment of latent tuberculosis infection. J Korean Med Assoc 2019;62:11-7.
25. Getahun H, Matteelli A, Abubakar I, Hauer B, Pontali E, Migliori GB. Advancing global programmatic management of latent tuberculosis infection for at risk populations. Eur Respir J 2016;47:1327-30.
26. Katsuda N, Hirosawa T, Reyer JA, Hamajima N. Roles of Public Health Centers (Hokenjo) in Tuberculosis Control in Japan. Nagoya J Med Sci 2015;77:19-28.
27. Local Government Association. Tackling tuberculosis: local government’s public health role. London: Local Government Association, Public Health England; 2018.